Does OSIMERTINIB Cause Inflammation? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Inflammation have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.2% of all adverse event reports for OSIMERTINIB.
52
Reports of Inflammation with OSIMERTINIB
0.2%
of all OSIMERTINIB reports
4
Deaths
13
Hospitalizations
How Dangerous Is Inflammation From OSIMERTINIB?
Of the 52 reports, 4 (7.7%) resulted in death, 13 (25.0%) required hospitalization, and 1 (1.9%) were considered life-threatening.
Is Inflammation Listed in the Official Label?
Yes, Inflammation is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Inflammation?
ADALIMUMAB (7,754)
METHOTREXATE (5,055)
ETANERCEPT (4,459)
RITUXIMAB (3,540)
SECUKINUMAB (3,515)
INFLIXIMAB (3,448)
TOCILIZUMAB (3,371)
ABATACEPT (3,284)
TOFACITINIB (3,241)
LEFLUNOMIDE (3,067)
Which OSIMERTINIB Alternatives Have Lower Inflammation Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN